New narcolepsy drug shows promise in early trial
NCT ID NCT06961266
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 26 times
Summary
This early-stage study tested a new drug called JZP441 in 6 adults with narcolepsy type 1, a condition that causes sudden sleep attacks. The goal was to see if the drug helps people stay awake during the day and to check for side effects. The study was stopped early, but results may still inform future treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Trial Site
Atlanta, Georgia, 30328, United States
-
Clinical Trial Site
Cincinnati, Ohio, 45245, United States
-
Clinical Trial Site
Columbia, South Carolina, 29201, United States
-
Clinical Trial Site
Austin, Texas, 78731, United States
Conditions
Explore the condition pages connected to this study.